Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Biochimica Et Biophysica Acta
|
May 22, 2003
Expression of mutant and wild-type TIMP3 in primary gingival fibroblasts from Sorsby's fundus dystrophy patients
Christine E Arris, Debra J Bevitt, Jeseem Mohamed, et al.
Biochimica Et Biophysica Acta
|
April 17, 2003
Expression of ADAMTS metalloproteinases in the retinal pigment epithelium derived cell line ARPE-19: transcriptional regulation by TNFalpha
Debra J Bevitt, Jeseem Mohamed, Jon B Catterall, et al.
Stroke
|
December 1, 2004
Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial
P Dusitanond, J W Eikelboom, G J Hankey, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
August 19, 2008
VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444)
, G J Hankey, A Algra, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Biochimica Et Biophysica Acta
|
May 22, 2003
Expression of mutant and wild-type TIMP3 in primary gingival fibroblasts from Sorsby's fundus dystrophy patients
Christine E Arris, Debra J Bevitt, Jeseem Mohamed, et al.
Biochimica Et Biophysica Acta
|
April 17, 2003
Expression of ADAMTS metalloproteinases in the retinal pigment epithelium derived cell line ARPE-19: transcriptional regulation by TNFalpha
Debra J Bevitt, Jeseem Mohamed, Jon B Catterall, et al.
Stroke
|
December 1, 2004
Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial
P Dusitanond, J W Eikelboom, G J Hankey, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
August 19, 2008
VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444)
, G J Hankey, A Algra, et al.
Page
of 2